Similar articles

• HLA-class II disparity is necessary for effective T cell mediated Graft-versus-Leukemia effects in NOD/scid mice engrafted with human acute lymphoblastic leukemia.

  Stevanović S, van Schie ML, Griffioen M, Falkenburg JH. Stevanović S, et al. Leukemia. 2013 Apr;27(4):985-7. doi: 10.1038/leu.2012.270. Epub 2012 Sep 17. Leukemia. 2013. PMID: 22982971 No abstract available.
• [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].

  Xia YJ, Gao QP, Wan CC, Cheng FJ, Liu ZX, Guo RC. Xia YJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Jul;26(7):404-7. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16251021 Chinese.
• Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.

  Delia M, Pastore D, Mestice A, Carluccio P, Perrone T, Gaudio F, Ricco A, Sgherza N, Albano F, Specchia G. Delia M, et al. Biol Blood Marrow Transplant. 2013 Mar;19(3):495-9. doi: 10.1016/j.bbmt.2012.11.015. Epub 2012 Nov 27. Biol Blood Marrow Transplant. 2013. PMID: 23200706
• Acute lymphoblastic leukemia.

  Farhi DC, Rosenthal NS. Farhi DC, et al. Clin Lab Med. 2000 Mar;20(1):17-28, vii. Clin Lab Med. 2000. PMID: 10702893 Review.
• Acute lymphoblastic leukemia.

  Onciu M. Onciu M. Hematol Oncol Clin North Am. 2009 Aug;23(4):655-74. doi: 10.1016/j.hoc.2009.04.009. Hematol Oncol Clin North Am. 2009. PMID: 19577163 Review.